NCT03416296 is a clinical trial in Morbidly Adherent Placenta, sponsored by Aljazeera Hospital.

Who is sponsoring NCT03416296?

NCT03416296 is sponsored by Aljazeera Hospital.

What condition does NCT03416296 study?

NCT03416296 studies Morbidly Adherent Placenta.

Is NCT03416296 still recruiting?

NCT03416296 is currently completed. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT03416296

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Completed Last updated 16 September 2021

What this trial tests

trial in Morbidly Adherent Placenta in 90 participants. Completed in 20 December 2019.

Timeline

15 March 2018

Primary endpoint
10 June 2019

20 December 2019

Quick facts

Lead sponsor	Aljazeera Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	15 March 2018
Primary completion	10 June 2019
Estimated completion	20 December 2019
Sites	1 location across Egypt

Conditions studied

Morbidly Adherent Placenta — all drugs for Morbidly Adherent Placenta →

Sponsor

Aljazeera Hospital

Who can join

Adults 20 to 43, female only, with Morbidly Adherent Placenta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Aljazeera Hospital trials

Trials by the same sponsor.

NCT06739759 — Ovarian Hyperstimulation Syndrome Prevention · NA · recruiting
NCT04778319 — Hysterosalpingography and Hysteroscopy in ICSI · NA · unknown
NCT04736095 — 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas · completed
NCT04749979 — Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin · NA · unknown
NCT04694677 — Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03416296 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aljazeera Hospital
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03416296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing